Chugai OTC Stock Buy Hold or Sell Recommendation

CHGCF -  USA Stock  

USD 27.57  0.00  0.00%

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Chugai Pharmaceutical is 'Strong Sell'. Macroaxis provides Chugai Pharmaceutical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CHGCF positions. The advice algorithm takes into account all of Chugai Pharmaceutical's available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Chugai Pharmaceutical's buy-and-hold perspective. Continue to Chugai Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Chugai and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Chugai Pharmaceutical.

Execute Chugai Pharmaceutical Buy or Sell Advice

The Chugai recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Chugai Pharmaceutical. Macroaxis does not own or have any residual interests in Chugai Pharmaceutical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Chugai Pharmaceutical's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Chugai PharmaceuticalBuy Chugai Pharmaceutical
Strong Sell

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds of Distress

Below AverageDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Chugai Pharmaceutical has a Mean Deviation of 0.8182, Standard Deviation of 1.68 and Variance of 2.82
Our investment recommendation module complements current analysts and expert consensus on Chugai Pharmaceutical. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Chugai Pharmaceutical is not overpriced, please confirm all Chugai Pharmaceutical fundamentals, including its cash per share, price to earnings to growth, and the relationship between the ebitda and book value per share . Given that Chugai Pharmaceutical has a price to earning of 20.36 X, we suggest you to validate Chugai Pharmaceutical market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Chugai Pharmaceutical Trading Alerts and Improvement Suggestions

Chugai Pharmaceutical generated a negative expected return over the last 90 days
About 60.0% of the company shares are held by company insiders
Latest headline from www.smartkarma.com: Health Care Virtus Health, Yunkang Group, Aier Eye Hospital Group, Chugai Pharmaceutical, Eris Lifesciences, Glaxosmithkline Pharmaceuticals and more - Smartkarma

Chugai Pharmaceutical Returns Distribution Density

The distribution of Chugai Pharmaceutical's historical returns is an attempt to chart the future uncertainty of Chugai Pharmaceutical's future price movements. The chart of the probability distribution of Chugai Pharmaceutical stock daily returns describes the distribution of returns around its average expected value. We use Chugai Pharmaceutical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Chugai Pharmaceutical returns is essential to provide solid investment advice for Chugai Pharmaceutical stock.
Mean Return-0.35Value At Risk-4.05
Potential Upside0.00Standard Deviation1.68
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Chugai Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Chugai Pharmaceutical Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Chugai Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Chugai Pharmaceutical stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Chugai stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.34
β
Beta against DOW0.10
σ
Overall volatility
1.71
Ir
Information ratio -0.11

Chugai Pharmaceutical Volatility Alert

Chugai Pharmaceutical exhibits very low volatility with skewness of -3.26 and kurtosis of 15.26. However, we advise investors to further study Chugai Pharmaceutical technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Chugai Pharmaceutical's otc stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Chugai Pharmaceutical's otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Chugai Pharmaceutical Implied Volatility

Chugai Pharmaceutical's implied volatility exposes the market's sentiment of Chugai Pharmaceutical stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chugai Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chugai Pharmaceutical stock will not fluctuate a lot when Chugai Pharmaceutical's options are near their expiration.

Chugai Pharmaceutical Fundamentals Vs Peers

Comparing Chugai Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Chugai Pharmaceutical's direct or indirect competition across all of the common fundamentals between Chugai Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Chugai Pharmaceutical or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Chugai Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Chugai Pharmaceutical by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Chugai Pharmaceutical to competition
FundamentalsChugai PharmaceuticalPeer Average
Return On Equity34.85 %(0.31) %
Return On Asset24.95 %(0.14) %
Profit Margin32.51 %(1.27) %
Operating Margin45.73 %(5.51) %
Current Valuation(380.7 B)16.62 B
Shares Outstanding1.64 B571.82 M
Shares Owned by Insiders60.17 %10.09 %
Shares Owned by Institutions17.55 %39.21 %
Price to Earning20.36 X28.72 X
Price to Book0.04 X9.51 X
Price to Sales0.04 X11.42 X
Revenue1190 B9.43 B
Gross Profit661.61 B27.38 B
EBITDA576.14 B3.9 B
Net Income387.36 B570.98 M
Cash and Equivalents431.82 B2.7 B
Cash per Share262.59 X5.01 X
Debt to Equity0.011 %48.70 %
Current Ratio3.41 X2.16 X
Book Value Per Share663.31 X1.93 K
Cash Flow from Operations409.3 B971.22 M
Earnings Per Share1.35 X3.12 X
Price to Earnings To Growth3.86 X4.89 X
Number of Employees7.66 K18.84 K
Beta0.65-0.15
Market Capitalization45.51 B19.03 B
Total Asset769.86 B29.47 B
Retained Earnings500.19 B9.33 B
Working Capital435.19 B1.48 B
Current Asset542.89 B9.34 B
Current Liabilities107.7 B7.9 B
Z Score1.08.72
Last Dividend Paid0.66

About Chugai Pharmaceutical Buy or Sell Advice

When is the right time to buy or sell Chugai Pharmaceutical? Buying financial instruments such as Chugai OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Chugai Pharmaceutical investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Chugai Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corona Opportunity Thematic Idea Now

Corona Opportunity
Corona Opportunity Theme
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 45 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
View All  Next Launch Corona Opportunity
Continue to Chugai Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.